Collagenase Total Occlusion-1 Trial.
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2016
At a glance
- Drugs Collagenase (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Acronyms CTO-1
- 08 Mar 2016 Results (n = 20) published in the Circulation.
- 22 Mar 2012 Actual end date (February 2012) added as reported by ClinicalTrials.gov.
- 22 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.